RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)
RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.
CVS Health: Buy Rating with Projected EPS Growth and Strategic Optimism Amid Retail Challenges
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...